The Rare Cancers Research (RaCaRe) Group explores the molecular mechanisms associated with cancerogenesis and tumour progression focusing on rare cancers. Through our research, we identify novel cancer-specific biomarkers and ultimately improve diagnostics and therapies. We are determined to pave the way towards precision medicine to effectively treat rare cancers.
Currently, we focus our attention on four specific rare cancers: Merkel cell carcinoma, a highly aggressive skin cancer associated with Merkel cell polyomavirus infection. Liposarcoma, a heterogeneous cancer with varying outcomes. Eccrine porocarcinoma, a blank slate amongst cancers.
Gastrointestinal stromal tumor (GIST), one of the most common types of soft tissue tumors with frequent resistance to current treatments.